[HTML] sciencedirect.com

[HTML][HTML] Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction

YJ Shi, CG Yang, WB Qiao, YC Liu, SY Liu… - European Journal of …, 2023 - Elsevier
Heart failure with preserved ejection fraction (HFpEF) represents a multifaceted syndrome
related to complex pathologic mechanisms. Sacubitril/valsartan (Sac/val) has demonstrated …
被引用次数：3 相关文章

Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction

YJ Shi, CG Yang, WB Qiao, YC Liu… - European journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Heart failure with preserved ejection fraction (HFpEF) represents a multifaceted syndrome
related to complex pathologic mechanisms. Sacubitril/valsartan (Sac/val) has demonstrated …

Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.

YJ Shi, CG Yang, WB Qiao, YC Liu, SY Liu… - European Journal of …, 2023 - europepmc.org
Heart failure with preserved ejection fraction (HFpEF) represents a multifaceted syndrome
related to complex pathologic mechanisms. Sacubitril/valsartan (Sac/val) has demonstrated …